Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

HANDOK Inc. Logo
Develops, manufactures, and distributes drugs, medical devices, and diagnostics.
South Korea
002390
Hanmi Pharm. Co., Ltd. Logo
A research-oriented biopharmaceutical company developing and manufacturing therapies.
South Korea
128940
Hanmi Science Co.,Ltd Logo
A holding company managing subsidiaries in the pharmaceutical and healthcare sectors.
South Korea
008930
Hansa Biopharma Logo
Develops antibody-cleaving enzyme technology for rare immunologic diseases.
Sweden
HNSA
Harmony Biosciences Holdings, Inc. Logo
Develops and commercializes therapies for rare neurological diseases.
United States of America
HRMY
HARROW, INC. Logo
An eyecare pharmaceutical company that develops and commercializes ophthalmic products.
United States of America
HROW
HCW Biologics Inc. Logo
Develops immunotherapies for diseases linked to aging and chronic inflammation.
United States of America
HCWB
Heidelberg Pharma AG Logo
Clinical-stage biopharma developing Amanitin-based ADCs for targeted cancer therapies.
Germany
HPHA
Helixmith Co., Ltd Logo
A biotechnology company specializing in the research and development of gene therapies.
South Korea
084990
HEMOGENYX PHARMACEUTICALS PLC Logo
Develops cell-based therapies for blood, autoimmune diseases, and viral infections.
United Kingdom
HEMO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.